NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19
Published
Author(s)
Jerilyn Izac, Edward Kwee, Adolfas Gaigalas, Lili Wang
Abstract
COVID-19 is a global pandemic caused by the highly infectious SARS-CoV-2 virus. Efforts to combat SARS-CoV-2 infection include mass vaccination and development of monoclonal and convalescent plasma therapeutics that require precise measurements of correlative, functional neutralizing antibodies that prevent virus infection. Developing rapid, safe, easy-to-use, and high-quality neutralization assays are essential for the success of the massive effort. Here, we developed a vesicular stomatitis virus-based neutralization assay that was capable of quantifying varying degrees of neutralization in patient serum samples. This assay has two detection readouts, flow cytometry and live cell imaging. The two readout methods produced consistent values of all 50% neutralization titers, further enhancing measurement confidence on the assay. Moreover, the use of available reference standards such as WHO IS enables quantification and standardization of the pseudovirus neutralization assay with neutralizing antibody titers measured in the unit of IU/mL. Quantitative and standardized neutralization assays are critical for reliable efficacy evaluation and comparison of numerous vaccines and therapeutics.
Izac, J.
, Kwee, E.
, Gaigalas, A.
and Wang, L.
(2024),
Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19, Humana Press/Springer, Totowa, NJ, [online], https://doi.org/10.1007/978-1-0716-3738-8_11, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=956266
(Accessed October 17, 2025)